Navigation Links
Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
Date:9/21/2007

wn aetiology. GEMZAR should be withdrawn if there is any sign of micro- angiopathic haemolytic anaemia.

Skin and allergic: Very common: Rash, pruritus, and alopecia. Rare: Vesiculation and ulceration. Very rare: Desquamation, bullous skin eruptions, and anaphylaxis.

Respiratory: Very common: Dyspnoea. Bronchospasm occurs uncommonly and is usually mild and transient, but parenteral therapy may be required. In the rare event of pulmonary oedema, interstitial pneumonitis, or adult respiratory distress syndrome (ARDS) gemcitabine should be stopped and supportive care initiated.

Cardiac: Very rare: Myocardial infarct, congestive heart failure, and arrhythmia.

Other: Very common: Influenza-like symptoms (fever, headache, back pain, chills, myalgia, asthenia, and anorexia), cough, rhinitis, malaise, sweating, insomnia, oedema or peripheral oedema, and somnolence. Common: Somnolence, fever, and asthenia. Very rare: Peripheral vasculitis and gangrene.

Combination use in breast cancer: When gemcitabine is used with paclitaxel the frequency of Grade 3 and 4 haematological toxicities increases, particularly neutropenia, although not associated with an increased incidence of infections. Fatigue and febrile neutropenia also occur more frequently with this combination.

Administration site conditions: Rare: Injection site reactions (mainly mild).

For full details of these and other side-effects, please see the Summary of Product Characteristics, approved in your country.

(i) Lilly Oncology, "Understanding Cancer: About Lung Cancer," Eli Lilly and Company, http://www.lillyoncology.com/patients_caregivers/lung_cancer.jsp?reqNavId=4.2.7, (January 19, 2007).

(ii) American Cancer Society, "How Is Non-Small Cell Lung Cancer Staged?," October 25, 2006, American Cancer Society,

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
2. Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007
3. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
4. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Malvern initiates European user group meetings for chemical imaging
9. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
10. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
11. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Patient engagement has ... consequently, organizations are turning to an assortment of ... As part of this evolving approach to patient ... communicate and engage patients throughout their experiences with ... empowerment. By mapping the patient journey and employing ...
(Date:7/11/2014)... July 11, 2014 According ... by Composition of Material, Application (Healthcare, Homeland security, ... Product (Personal Instrument, Hand-Held Instruments, Fixed, and Installed ... to 2013 - 2020", published by MarketsandMarkets, the Scintillator Market ... 5.62% from 2014 to 2020, and reach $479.16 ...
(Date:7/11/2014)... -- On Thursday, July 10, 2014, ... Jones Industrial Average finished the day 0.42% lower at 16,915.07, ... losses were broad based as eight out of ten sectors ... Sector Index ended the day at 711.88, down 0.02%, while ... Investor-Edge has initiated coverage on the following equities: Covidien PLC ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4
... Inc. today announced that data from a Phase 1/2 study, ... Proceedings of the National Academy of Sciences, demonstrate the ... action human growth hormone, compared to therapy with native hormone. ... treated with ARX201, which was generated with Ambrx,s ReCODE™ technology. ...
... Korea, May 25, 2011 New findings presented from ... program showed that the safety profile of STELARA and ... time in adults with moderate to severe plaque psoriasis ... reported findings from an analysis of four placebo-controlled Phase ...
Cached Medicine Technology:Proceedings of the National Academy of Sciences Report Superiority of Human Growth Hormone Generated with Ambrx Technology 2New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 2New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 3New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 4New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 5New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 6New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 7New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 8New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 9New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 10New Four Year STELARA® Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis 11
(Date:7/12/2014)... July 12, 2014 Sean Francis, owner of the ... special challenges to his clients. He’s also known for his support ... found a way to combine the two and is excited to ... for the Boys and Girls Club. , The funds are the ... on June 23rd. Francis sent out emails and asked his clients ...
(Date:7/12/2014)... 12, 2014 Using and carrying around ... two inventors from Ashland, Va., decided that there needed ... inspired us to conceive of our design," he said. ... KIDNEY KOVER, which provides an inconspicuous way to use ... as well as promotes comfort and peace of mind. ...
(Date:7/12/2014)... With prom shopping reaching its final days, VogueQueen.com, a ... showcase its new and trendy apparels. Recently, the company ... its online shop. Additionally, it is now providing huge ... According to the company’s sales manager, the promotion will ... , He says, “Now, worldwide clients can order cheap ...
(Date:7/12/2014)... Wright & Schulte LLC has filed a ... subsidiary of Johnson & Johnson, on behalf of an Ohio ... a metal-on-metal DePuy Pinnacle hip replacement and had to undergo ... implant. The DePuy hip lawsuit was filed July 7, 2014, ... No. 3:14-cv-2427) where DePuy Pinnacle Hip lawsuit litigation is ...
(Date:7/12/2014)... 12, 2014 Doylestown Hospital recently conducted ... of men’s health questions. Paddock tackles topics including ... why women live longer than men, and testosterone replacement ... Made Simple featured on Doylestown Hospital’s website, Dr. ... at any age. If you notice pain, bulging, or ...
Breaking Medicine News(10 mins):Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2
... of scientists, led by H. Lundbeck A/S and King,s ... research academic-industry collaboration projects to find new methods for ... Novel Methods leading to New Medications in Depression ... top scientists from academic institutions with a wide range ...
... onPoint ... to announce that Joe Baffone, an 18-year oncology executive with Sanofi-Aventis has joined onPoint ... ... full service healthcare data solutions and reimbursement analytics firm, is proud to announce that ...
... , ... TBT Payment Acceptance Solutions offers merchant services across the southeast such as credit ... and loyalty cards. ,Whether you are a merchant in need of a payment ... with an established and trusted company, www.tbtpas.com allows for convenient access ...
... ... company CTW, Inc. of Mississippi and Massachusetts-based medical device manufacturer Tegra Medical to join ... ... private equity firm based in Boston, MA, is pleased to announce its majority investment ...
... , INDIANAPOLIS , Jan. ... solutions, has announced the completion of its $8 million ... Menlo Park, California .  The funding will allow Orbis ... and, in turn, help alleviate the nation,s wide-spread nursing shortages. ...
... , PORT-AU-PRINCE, Haiti , Jan. 19 , ... death toll likely well over 100,000 3 million people displaced or ... quake: 4 to 4.5 million) , Conditions in ... the quake are now scattered across 243 different locations in Port-au-Prince ...
Cached Medicine News:Health News:Largest academic-industry collaboration for drug discovery in depression and schizophrenia launched 2Health News:Largest academic-industry collaboration for drug discovery in depression and schizophrenia launched 3Health News:Oncology Industry Veteran, Joe Baffone, Joins onPoint Oncology, LLC. 2Health News:TBT Payment Acceptance Solutions Announces Launch of Redesigned “User-Friendly” Website, www.tbtpas.com 2Health News:Riverside Partners Announces Acquisition of CTW, Inc. and Partnership with Tegra Medical 2Health News:Riverside Partners Announces Acquisition of CTW, Inc. and Partnership with Tegra Medical 3Health News:Riverside Partners Announces Acquisition of CTW, Inc. and Partnership with Tegra Medical 4Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 2Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 3Health News:Orbis Education Secures $8.0 Million in Funding for Expanding Online Nursing Education Platform 4Health News:World Vision Situation Update: More Aid Reaching Many Survivors, but Conditions Remain Dire 2Health News:World Vision Situation Update: More Aid Reaching Many Survivors, but Conditions Remain Dire 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: